HIV / AIDS

Brown University researchers propose thinking about pre-exposure prophylaxis (PrEP) as a nine-step continuum of preventive care, one that improves uptake and focuses on retention in care.

Catch up on last month's top infectious disease news coverage from Contagion®.

New research suggests that human and viral genetics account for one third of the differences in disease progression rates in HIV-positive individuals.

Scientists are hopeful that a new two-drug regimen will simplify treatment for HIV patients while exposing them to fewer side effects.

Could a new process called long-acting slow effective release antiretroviral therapy, or LASER ART, be a game-changer in treating HIV?

A survey spanning almost two decades shows a consistent increase in condom-less anal sex and number of sexual partners in MSM as many see antiretroviral therapy as a "protective back-up" measure to avoid HIV infection.

The Centers for Disease Control and Prevention recently published a study detailing a case of Ebola virus RNA persistence in the semen of a male Ebola survivor with HIV.

The Centers for Disease Control and Prevention recently investigated three incidents of rare microsporidiosis infections in transplant patients in the United States.

The Centers for Disease Control and Prevention is reporting that annual HIV infections declined from 2008 to 2014, but this decrease was not seen across all groups.

Research presented at the recent Conference on Retroviruses and Opportunistic Infections shows that more individuals are aware of their HIV and hepatitis C (HCV) status, but more work is still needed.

National Institutes of Health (NIH) scientists provide an explanation for how an anti-alpha-4 beta-7 antibody treatment resulted in sustained remission of SIV in a monkey experiment.

The Duke Human Vaccine Institute may have discovered an HIV-destroying antibody that is capable of neutralizing up to 99% of the virus, which would make it the most powerful one yet found.

A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.

As cardiovascular disease is becoming one of the most significant comorbidities of people with HIV, the National Institutes of Health continues to enroll people in its landmark study, Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

UNAIDS calls for access to HPV educational materials as well as cervical cancer screening and treatment for HIV-positive women.

Researchers have found incidence of multidrug-resistant HIV-1 infection, despite the use of preexposure prophylaxis (PrEP).

Researchers from the University of Pennsylvania Perelman School of Medicine show that many young transgender women are aware of HIV PrEP and have positive attitudes toward it.

Johns Hopkins University researchers conducted a survey with the goal of finding out the prevalence of HIV testing among nonclinical community-based organizations in Baltimore, Maryland.

Higher rates of self-reported drug use exist among the HIV-positive population, highlighting the need for interventions in at-risk populations.

Researchers from the University of Pennsylvania identify characteristics of HIV-1 strains that are able to get through innate protective barriers and cause infection through sexual intercourse.

Felix Kleefeld, of Berlin, Germany, and colleagues examined how eradicating HCV affected the cognition of patients in a study published in Neurology in December 2016.

This article is the second part of two-part coverage on a study conducted by Rutgers University researchers that analyzes the effects of misdiagnosing fungal infections on the increasing rates of antimicrobial resistance.

A recent study conducted by Rutgers University researchers analyzes the effects of misdiagnosing fungal infections on the increasing rates of antimicrobial resistance.

Oluwatoyin (Toyin) Adeyemi, MD, attending physician of infectious diseases, at Cook County Health and Hospital System, discusses the CORE Healthy Aging Initiative (CHAI).

UCLA researchers have developed an online risk assessment calculator that will allow individuals to check their “PrEP score.”